Harm reduction: evidence, impacts and challenges
-10-
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...f their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all the unwanted effects of medications are mentioned.
more
Externalising disorders
Chapter D.3
Mood disorders
Chapter E.4
2018 edition
Anxiety disorders
Chapter F.5
Other disorders Chapter H.1
Other disorders
Chapter H.3
Miscellaneous
Chapter J.6
Published: February 23, 2010
https://doi.org/10.1371/journal.pmed.1000235
Volume 7 | Issue 2 | e1000235
Otros trastornos
Capítulo H.3
Edición 2018
Edición: Matías Irarrázaval & Andres Martin
Traducción: Beatriz Ortega & Macarena Espinoza
Received: 16/11/2013 - Accepted: 23/03/2014 - Published: 27/07/2014
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
Lancet Psychiatry 2016;3: 415–24
DEP supporting material
• Person stories
• Role plays – role plays 3 and 4 are extra material for
supplementary activities
• Multiple choice questions
• Video links
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm...ents (e.g., interpersonal psychotherapy or cognitive behavioural therapy, including behavioural activation) or antidepressant medication (e.g., SSRIsi and tricyclic antidepressants) be considered in adults with moderate-severe depression. Health care workers need to know whether these treatments have different effects, including side-effects, in treating depressive disorder in the short and long term, in order to improve clinical decision-making.
more
This paper provides information to assist World Bank and GFDRR staff in affecting disability-inclusive DRM. It is based upon desk reviews of existing practice, as well as consultations with experts in the field of disability-inclusive DRM. The paper:
- Illustrates promising practices related to... disability-inclusive DRM;
- Identifies key gaps in knowledge and practices;
- Identifies value-added areas for GFDRR and the World Bank, including specific actions they can take to advance the disability and social inclusion agenda in DRM;
It includess:
- Relevant guiding international policy frameworks;
- Disability inclusion in the priorities of the Sendai Framework for Disaster Risk Reduction;
- Illustrations of promising practices in disability-inclusive DRM;
- An annex of resources related to disability and DRM.
more